OnKure Therapeutics, Valuation
| OKUR Stock | 8.38 0.33 4.10% |
At this time, the company appears to be overvalued. OnKure Therapeutics, holds a recent Real Value of USD8.04 per share. The prevailing price of the company is USD8.38. Our model determines the value of OnKure Therapeutics, from analyzing the company fundamentals such as net income of (35.31 M), and Net Asset of 35.73 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that OnKure Therapeutics,'s price fluctuation is slightly risky at this time. Calculation of the real value of OnKure Therapeutics, is based on 3 months time horizon. Increasing OnKure Therapeutics,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the OnKure stock is determined by what a typical buyer is willing to pay for full or partial control of OnKure Therapeutics,. Since OnKure Therapeutics, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of OnKure Stock. However, OnKure Therapeutics,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.38 | Real 8.04 | Hype 7.75 | Naive 6.53 |
The intrinsic value of OnKure Therapeutics,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence OnKure Therapeutics,'s stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of OnKure Therapeutics, helps investors to forecast how OnKure stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of OnKure Therapeutics, more accurately as focusing exclusively on OnKure Therapeutics,'s fundamentals will not take into account other important factors: OnKure Therapeutics, Total Value Analysis
OnKure Therapeutics, is now anticipated to have valuation of 0 with market capitalization of 0, debt of 137.58 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the OnKure Therapeutics, fundamentals before making equity appraisal based on enterprise value of the companyOnKure Therapeutics, Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of OnKure connotes not a very effective usage of assets in December.OnKure Therapeutics, Profitability Analysis
Net Loss for the year was (35.31 M) with profit before overhead, payroll, taxes, and interest of 0.About OnKure Therapeutics, Valuation
The stock valuation mechanism determines OnKure Therapeutics,'s current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of OnKure Therapeutics, based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of OnKure Therapeutics,. We calculate exposure to OnKure Therapeutics,'s market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of OnKure Therapeutics,'s related companies.OnKure Therapeutics, Growth Indicators
Investing in growth stocks can be very risky. If the company such as OnKure Therapeutics, does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 137 M |
Additional Tools for OnKure Stock Analysis
When running OnKure Therapeutics,'s price analysis, check to measure OnKure Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OnKure Therapeutics, is operating at the current time. Most of OnKure Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of OnKure Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OnKure Therapeutics,'s price. Additionally, you may evaluate how the addition of OnKure Therapeutics, to your portfolios can decrease your overall portfolio volatility.